These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 15004663)

  • 1. The comparison of radiotherapy techniques for treatment of the prostate cancer: the three-field vs. the four-field.
    Milecki P; Piotrowski T; Dymnicka M
    Neoplasma; 2004; 51(1):64-9. PubMed ID: 15004663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
    Luxton G; Hancock SL; Boyer AL
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
    O'Neill L; Armstrong J; Buckney S; Assiri M; Cannon M; Holmberg O
    Radiother Oncol; 2008 Jul; 88(1):61-6. PubMed ID: 18453021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
    Mock U; Bogner J; Georg D; Auberger T; Pötter R
    Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose distribution in 3-dimensional conformal radiotherapy for prostate cancer: comparison of two treatment techniques (six coplanar fields and two dynamic arcs).
    Jereczek-Fossa BA; Cattani F; D'Onofrio A; Cambria R; Kowalczyk A; Corallo A; Vavassori A; Zerini D; Ivaldi GB; DeCobelli O; Orecchia R
    Radiother Oncol; 2006 Dec; 81(3):294-302. PubMed ID: 17113670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
    Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
    Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients.
    Kassim I; Dirkx ML; Heijmen BJ
    Radiother Oncol; 2009 Jul; 92(1):62-7. PubMed ID: 19278745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.
    Brabbins D; Martinez A; Yan D; Lockman D; Wallace M; Gustafson G; Chen P; Vicini F; Wong J
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):400-8. PubMed ID: 15667959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the optimal co-planar field arrangement for use in the boost phase of dose escalated conformal radiotherapy for localized prostate cancer.
    Khoo VS; Bedford JL; Webb S; Dearnaley DP
    Br J Radiol; 2001 Feb; 74(878):177-82. PubMed ID: 11718391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy of prostate cancer with multileaf collimators (MLCs) optimization of the undulating dose distribution at the MLC edge.
    Koelbl O; Schwab F; Bratengeier K; Vordermark D; Flentje M
    Strahlenther Onkol; 2005 Feb; 181(2):108-12. PubMed ID: 15702299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer.
    Bayley AJ; Catton CN; Haycocks T; Kelly V; Alasti H; Bristow R; Catton P; Crook J; Gospodarowicz MK; McLean M; Milosevic M; Warde P
    Radiother Oncol; 2004 Jan; 70(1):37-44. PubMed ID: 15036850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simplified intensity-modulated arc therapy for dose escalated prostate cancer radiotherapy.
    Bauman G; Gete E; Chen JZ; Wong E
    Med Dosim; 2004; 29(1):18-25. PubMed ID: 15023389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment.
    Gauthier I; Carrier JF; Béliveau-Nadeau D; Fortin B; Taussky D
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1128-33. PubMed ID: 19147306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of spatial dose gradients and probability density function to evaluate the effect of internal organ motion for prostate IMRT treatment planning.
    Jiang R; Barnett RB; Chow JC; Chen JZ
    Phys Med Biol; 2007 Mar; 52(5):1469-84. PubMed ID: 17301465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative radiation treatment for rectal cancer: comparison of target coverage and small bowel NTCP in conventional vs. 3D-conformal planning.
    Cella L; Ciscognetti N; Martin G; Liuzzi R; Punzo G; Solla R; Farella A; Salvatore M; Pacelli R
    Med Dosim; 2009; 34(1):75-81. PubMed ID: 19181259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit of using biologic parameters (EUD and NTCP) in IMRT optimization for treatment of intrahepatic tumors.
    Thomas E; Chapet O; Kessler ML; Lawrence TS; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):571-8. PubMed ID: 15890602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
    Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the conventional 'box technique' with two different 'conformal' beam arrangements for prostate cancer treatment.
    Magrini SM; Cellai E; Rossi F; Pertici M; Compagnucci A; Biti GP
    Cancer Radiother; 1999; 3(3):215-20. PubMed ID: 10394339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiobiological impact of reduced margins and treatment technique for prostate cancer in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP).
    Jensen I; Carl J; Lund B; Larsen EH; Nielsen J
    Med Dosim; 2011; 36(2):130-7. PubMed ID: 20488692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dosimetric analysis of radiotherapy with middle shielding blocks of different widths at the lower cervical supraclavicular field for stage N2-3 nasopharyngeal carcinoma].
    Li FM; Luo W; He ZC; Zhang L; Sun Y; Qin WJ; Lu LX; Han F; Liu XQ; Liu MZ
    Ai Zheng; 2007 Oct; 26(10):1127-32. PubMed ID: 17927886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.